360 related articles for article (PubMed ID: 2416838)
1. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
2. The in vitro effects of D-penicillamine upon anti-AChR production by thymic and peripheral blood lymphocytes from patients with myasthenia gravis.
Scadding GK; Calder L; Newsom-Davis J
Muscle Nerve; 1983; 6(9):656-60. PubMed ID: 6606776
[TBL] [Abstract][Full Text] [Related]
3. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
[TBL] [Abstract][Full Text] [Related]
4. Greatly increased autoantibody production in myasthenia gravis by thymocyte suspensions prepared with proteolytic enzymes.
Willcox HN; Newsom-Davis J; Calder LR
Clin Exp Immunol; 1983 Nov; 54(2):378-86. PubMed ID: 6317238
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to acetylcholine receptor and tetanus toxoid: in vitro synthesis by thymic lymphocytes.
Lisak RP; Levinson AI; Zweiman B; Kornstein MJ
J Immunol; 1986 Aug; 137(4):1221-5. PubMed ID: 3488346
[TBL] [Abstract][Full Text] [Related]
6. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptor antibody synthesis in lymphocyte cultures.
McLachlan SM; Nicholson LV; Venables G; Mastalgia FL; Bates D; Smith BR; Hall R
J Clin Lab Immunol; 1981 May; 5(3):137-42. PubMed ID: 7241564
[TBL] [Abstract][Full Text] [Related]
8. Thymus cells in myasthenia gravis selectively enhance production of anti-acetylcholine-receptor antibody by autologous blood lymphocytes.
Newsom-Davis J; Willcox N; Calder L
N Engl J Med; 1981 Nov; 305(22):1313-8. PubMed ID: 7290153
[TBL] [Abstract][Full Text] [Related]
9. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
Shinomiya N; Yata J
Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
[TBL] [Abstract][Full Text] [Related]
10. Genetic restriction of autoreactive acetylcholine receptor-specific T lymphocytes in myasthenia gravis.
Hohlfeld R; Conti-Tronconi B; Kalies I; Bertrams J; Toyka KV
J Immunol; 1985 Oct; 135(4):2393-9. PubMed ID: 2411794
[TBL] [Abstract][Full Text] [Related]
11. The effects of T cell subpopulations and recombinant interleukin (IL)-2 on peripheral B cell function in patients with myasthenia gravis.
Zhang J; Zhou WB; Wang HL; Guo SS
Hum Antibodies; 1997; 8(2):90-4. PubMed ID: 9289393
[TBL] [Abstract][Full Text] [Related]
12. In vitro T-cell dependent B-cell activity in myasthenia gravis.
Limburg PC; Hummel-Tappel E; Oosterhuis HJ; The TH
Clin Exp Immunol; 1985 Jul; 61(1):31-8. PubMed ID: 3876181
[TBL] [Abstract][Full Text] [Related]
13. [In vitro immunoglobulin synthesis by peripheral blood mononuclear cells from patients with myasthenia gravis].
Miyazaki Y; Arikawa E; Kubota H; Yagi K; Tanabe H
Rinsho Shinkeigaku; 1990 Jan; 30(1):1-6. PubMed ID: 2331813
[TBL] [Abstract][Full Text] [Related]
14. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
16. Variable corticosteroid sensitivity of thymic cortex and medullary peripheral-type lymphoid tissue in myasthenia gravis patients: structural and functional effects.
Willcox N; Schluep M; Sommer N; Campana D; Janossy G; Brown AN; Newsom-Davis J
Q J Med; 1989 Nov; 73(271):1071-87. PubMed ID: 2623139
[TBL] [Abstract][Full Text] [Related]
17. The myasthenia gravis thymus: a rare source of human autoantibody-secreting plasma cells for testing potential therapeutics.
Hill ME; Shiono H; Newsom-Davis J; Willcox N
J Neuroimmunol; 2008 Sep; 201-202():50-6. PubMed ID: 18722675
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.
Saito R; Onodera H; Tago H; Suzuki Y; Shimizu M; Matsumura Y; Kondo T; Itoyama Y
J Neuroimmunol; 2005 Dec; 170(1-2):172-8. PubMed ID: 16214223
[TBL] [Abstract][Full Text] [Related]
19. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
20. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
